List of Tables
Table 1. Global Dabigatran Etexilate Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Dabigatran Etexilate Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Dabigatran Etexilate Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Dabigatran Etexilate Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Dabigatran Etexilate Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Dabigatran Etexilate Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Dabigatran Etexilate Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Dabigatran Etexilate Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Dabigatran Etexilate Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Dabigatran Etexilate Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Dabigatran Etexilate Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Dabigatran Etexilate Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dabigatran Etexilate Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dabigatran Etexilate Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dabigatran Etexilate Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Dabigatran Etexilate Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Dabigatran Etexilate Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Dabigatran Etexilate Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Dabigatran Etexilate Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Dabigatran Etexilate Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Dabigatran Etexilate Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Dabigatran Etexilate Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Dabigatran Etexilate Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Dabigatran Etexilate Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Dabigatran Etexilate Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Dabigatran Etexilate Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Dabigatran Etexilate Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Dabigatran Etexilate Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Dabigatran Etexilate Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Dabigatran Etexilate Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Dabigatran Etexilate Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Dabigatran Etexilate Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Dabigatran Etexilate Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Dabigatran Etexilate Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Dabigatran Etexilate Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Dabigatran Etexilate Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Dabigatran Etexilate Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Dabigatran Etexilate Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Dabigatran Etexilate Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Dabigatran Etexilate Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Dabigatran Etexilate Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Dabigatran Etexilate Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Dabigatran Etexilate Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Dabigatran Etexilate Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Dabigatran Etexilate Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Dabigatran Etexilate Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Dabigatran Etexilate Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Dabigatran Etexilate Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Dabigatran Etexilate Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Dabigatran Etexilate Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Dabigatran Etexilate Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Dabigatran Etexilate Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Dabigatran Etexilate Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Dabigatran Etexilate Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Dabigatran Etexilate Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Dabigatran Etexilate Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Dabigatran Etexilate Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Dabigatran Etexilate Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Dabigatran Etexilate Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Dabigatran Etexilate Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Dabigatran Etexilate Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Dabigatran Etexilate Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Dabigatran Etexilate Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Dabigatran Etexilate Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Dabigatran Etexilate Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Dabigatran Etexilate Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Dabigatran Etexilate Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Dabigatran Etexilate Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Boehringer Ingelheim Company Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Boehringer Ingelheim Dabigatran Etexilate Drugs Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. MSN Company Information
Table 76. MSN Description and Business Overview
Table 77. MSN Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. MSN Dabigatran Etexilate Drugs Product
Table 79. MSN Recent Developments/Updates
Table 80. Camber Pharmaceuticals Company Information
Table 81. Camber Pharmaceuticals Description and Business Overview
Table 82. Camber Pharmaceuticals Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Camber Pharmaceuticals Dabigatran Etexilate Drugs Product
Table 84. Camber Pharmaceuticals Recent Developments/Updates
Table 85. Glenmark Pharmaceuticals Company Information
Table 86. Glenmark Pharmaceuticals Description and Business Overview
Table 87. Glenmark Pharmaceuticals Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Glenmark Pharmaceuticals Dabigatran Etexilate Drugs Product
Table 89. Glenmark Pharmaceuticals Recent Developments/Updates
Table 90. Hetero Labs Company Information
Table 91. Hetero Labs Description and Business Overview
Table 92. Hetero Labs Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Hetero Labs Dabigatran Etexilate Drugs Product
Table 94. Hetero Labs Recent Developments/Updates
Table 95. Novadoz Company Information
Table 96. Novadoz Description and Business Overview
Table 97. Novadoz Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Novadoz Dabigatran Etexilate Drugs Product
Table 99. Novadoz Recent Developments/Updates
Table 100. Apotex Company Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Apotex Dabigatran Etexilate Drugs Product
Table 104. Apotex Recent Developments/Updates
Table 105. Alembic Pharmaceuticals Company Information
Table 106. Alembic Pharmaceuticals Description and Business Overview
Table 107. Alembic Pharmaceuticals Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Alembic Pharmaceuticals Dabigatran Etexilate Drugs Product
Table 109. Alembic Pharmaceuticals Recent Developments/Updates
Table 110. Alkem Labs Company Information
Table 111. Alkem Labs Description and Business Overview
Table 112. Alkem Labs Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Alkem Labs Dabigatran Etexilate Drugs Product
Table 114. Alkem Labs Recent Developments/Updates
Table 115. Chia Tai Tianqing Pharmaceutical Company Information
Table 116. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 117. Chia Tai Tianqing Pharmaceutical Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Chia Tai Tianqing Pharmaceutical Dabigatran Etexilate Drugs Product
Table 119. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 120. Sihuan Pharmaceutical Company Information
Table 121. Sihuan Pharmaceutical Description and Business Overview
Table 122. Sihuan Pharmaceutical Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sihuan Pharmaceutical Dabigatran Etexilate Drugs Product
Table 124. Sihuan Pharmaceutical Recent Developments/Updates
Table 125. Qilu Pharmaceutical Company Information
Table 126. Qilu Pharmaceutical Description and Business Overview
Table 127. Qilu Pharmaceutical Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Qilu Pharmaceutical Dabigatran Etexilate Drugs Product
Table 129. Qilu Pharmaceutical Recent Developments/Updates
Table 130. Chengdu Brilliant Pharmaceutical Company Information
Table 131. Chengdu Brilliant Pharmaceutical Description and Business Overview
Table 132. Chengdu Brilliant Pharmaceutical Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Chengdu Brilliant Pharmaceutical Dabigatran Etexilate Drugs Product
Table 134. Chengdu Brilliant Pharmaceutical Recent Developments/Updates
Table 135. Nanjing Hicin Pharmaceutical Company Information
Table 136. Nanjing Hicin Pharmaceutical Description and Business Overview
Table 137. Nanjing Hicin Pharmaceutical Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Nanjing Hicin Pharmaceutical Dabigatran Etexilate Drugs Product
Table 139. Nanjing Hicin Pharmaceutical Recent Developments/Updates
Table 140. Zhejiang Huahai Pharmaceutical Company Information
Table 141. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 142. Zhejiang Huahai Pharmaceutical Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Zhejiang Huahai Pharmaceutical Dabigatran Etexilate Drugs Product
Table 144. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 145. Kelun Pharmaceutical Company Information
Table 146. Kelun Pharmaceutical Description and Business Overview
Table 147. Kelun Pharmaceutical Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Kelun Pharmaceutical Dabigatran Etexilate Drugs Product
Table 149. Kelun Pharmaceutical Recent Developments/Updates
Table 150. Hansoh Pharmaceutical Company Information
Table 151. Hansoh Pharmaceutical Description and Business Overview
Table 152. Hansoh Pharmaceutical Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Hansoh Pharmaceutical Dabigatran Etexilate Drugs Product
Table 154. Hansoh Pharmaceutical Recent Developments/Updates
Table 155. Easton Biopharmaceuticals Company Information
Table 156. Easton Biopharmaceuticals Description and Business Overview
Table 157. Easton Biopharmaceuticals Dabigatran Etexilate Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Easton Biopharmaceuticals Dabigatran Etexilate Drugs Product
Table 159. Easton Biopharmaceuticals Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Dabigatran Etexilate Drugs Distributors List
Table 163. Dabigatran Etexilate Drugs Customers List
Table 164. Dabigatran Etexilate Drugs Market Trends
Table 165. Dabigatran Etexilate Drugs Market Drivers
Table 166. Dabigatran Etexilate Drugs Market Challenges
Table 167. Dabigatran Etexilate Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Dabigatran Etexilate Drugs
Figure 2. Global Dabigatran Etexilate Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Dabigatran Etexilate Drugs Market Share by Type: 2025 & 2032
Figure 4. Capsules Product Picture
Figure 5. Oral Pellets Product Picture
Figure 6. Global Dabigatran Etexilate Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Dabigatran Etexilate Drugs Market Share by Application: 2025 & 2032
Figure 8. Adult Deep Vein Thrombosis
Figure 9. Pulmonary Embolism
Figure 10. Atrial Fibrillation
Figure 11. Other
Figure 12. Global Dabigatran Etexilate Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Dabigatran Etexilate Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global Dabigatran Etexilate Drugs Sales (K Units), 2021–2032
Figure 15. Global Dabigatran Etexilate Drugs Average Price (US$/Unit), 2021–2032
Figure 16. Dabigatran Etexilate Drugs Report Years Considered
Figure 17. Dabigatran Etexilate Drugs Sales Share by Manufacturers in 2025
Figure 18. Global Dabigatran Etexilate Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Dabigatran Etexilate Drugs Players: Market Share by Revenue in Dabigatran Etexilate Drugs in 2025
Figure 20. Dabigatran Etexilate Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Dabigatran Etexilate Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Dabigatran Etexilate Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America Dabigatran Etexilate Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Dabigatran Etexilate Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe Dabigatran Etexilate Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Dabigatran Etexilate Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Dabigatran Etexilate Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Dabigatran Etexilate Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America Dabigatran Etexilate Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Dabigatran Etexilate Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Dabigatran Etexilate Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Dabigatran Etexilate Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Dabigatran Etexilate Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Dabigatran Etexilate Drugs by Type (2021–2032)
Figure 55. Global Dabigatran Etexilate Drugs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Dabigatran Etexilate Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Dabigatran Etexilate Drugs by Application (2021–2032)
Figure 58. Global Dabigatran Etexilate Drugs Price (US$/Unit) by Application (2021–2032)
Figure 59. Dabigatran Etexilate Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
